Coronavirus (CoV) proteins in GtoPdb v. 2023.3
Coronaviruses are large, often spherical, enveloped, single-stranded positive-sense RNA
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
Coronavirus (CoV) proteins in GtoPdb v. 2022.3
Coronaviruses are large, often spherical, enveloped, single-stranded positive-sense RNA
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
Coronavirus (CoV) proteins in GtoPdb v. 2021.3
Coronaviruses are large, often spherical, enveloped, single-stranded positive-sense RNA
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
viruses, ranging in size from 80-220 nm. Their genomes and protein structures are highly …
[HTML][HTML] Virus-, host-, immune-based targets for COVID-19 therapy
W Liu, HL Zhu, Y Duan - Drug Discovery Today, 2020 - ncbi.nlm.nih.gov
A clinical case with pneumonia-like symptoms caused by SARS-CoV-2 was first recorded in
the Wuhan city of Hubei province, China [1]. Within a few weeks of its emergence, more than …
the Wuhan city of Hubei province, China [1]. Within a few weeks of its emergence, more than …
[PDF][PDF] Proteome Organization of COVID-19: Illustrating Targets for Vaccine Development.
Abstract 'COVID-19'the recent virulent viral infection had influenced the lives of millions
globally leading to both loss of life, economic and financial crisis. Coronavirus belongs to …
globally leading to both loss of life, economic and financial crisis. Coronavirus belongs to …
[PDF][PDF] A summary of viral targets and recently released PDB IDs of SARS-CoV-2
Drug discovery and development against coronavirus disease 2019 (COVID-19) is the
utmost need and the most challenging tas of the hour. Many research groups from different …
utmost need and the most challenging tas of the hour. Many research groups from different …
COVID-19-Molecular Aspects of the Disease, Diagnosis and Treatment. What do we Know so Far?
RMÃO Flores - Biomedical Journal of Scientific & Technical …, 2024 - ideas.repec.org
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by a virus called
SARS-CoV-2. It first emerged in January 2019 in Wuhan, China, and has since spread to …
SARS-CoV-2. It first emerged in January 2019 in Wuhan, China, and has since spread to …
[PDF][PDF] Coronavirus Current and New Potential Therapeutic Targets: A Review.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence in
late 2019 marked the introduction of a highly spread viral pathogen threatening human …
late 2019 marked the introduction of a highly spread viral pathogen threatening human …
Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses
There are 7 known human pathogenic coronaviruses, which are HCoV-229E, HCoV-OC43,
HCoV-NL63, HCoV-HKU1, MERS-CoV, SARS-CoV and SARS-CoV-2. While SARS-CoV-2 …
HCoV-NL63, HCoV-HKU1, MERS-CoV, SARS-CoV and SARS-CoV-2. While SARS-CoV-2 …
[HTML][HTML] Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19
Coronavirus belongs to the family of Coronaviridae, comprising single-stranded, positive-
sense RNA genome (+ ssRNA) of around 26 to 32 kilobases, and has been known to cause …
sense RNA genome (+ ssRNA) of around 26 to 32 kilobases, and has been known to cause …